OrthoPediatrics Future Growth
Future criteria checks 1/6
OrthoPediatrics is forecast to grow earnings and revenue by 22.6% and 16.8% per annum respectively while EPS is expected to grow by 23.1% per annum.
Key information
22.6%
Earnings growth rate
23.1%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 16.8% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 282 | -17 | N/A | N/A | 6 |
| 12/31/2025 | 240 | -24 | N/A | N/A | 6 |
| 12/31/2024 | 203 | -29 | N/A | N/A | 6 |
| 9/30/2024 | 190 | -28 | -51 | -31 | N/A |
| 6/30/2024 | 175 | -25 | -51 | -29 | N/A |
| 3/31/2024 | 162 | -22 | -48 | -27 | N/A |
| 12/31/2023 | 149 | -21 | -46 | -27 | N/A |
| 9/30/2023 | 142 | -22 | -35 | -23 | N/A |
| 6/30/2023 | 137 | 1 | -31 | -20 | N/A |
| 3/31/2023 | 130 | 4 | -35 | -24 | N/A |
| 12/31/2022 | 122 | 1 | -32 | -22 | N/A |
| 9/30/2022 | 116 | 9 | -32 | -20 | N/A |
| 6/30/2022 | 106 | -12 | -33 | -15 | N/A |
| 3/31/2022 | 100 | -15 | -31 | -15 | N/A |
| 12/31/2021 | 98 | -16 | -30 | -13 | N/A |
| 9/30/2021 | 92 | -30 | -30 | -12 | N/A |
| 6/30/2021 | 89 | -33 | -27 | -15 | N/A |
| 3/31/2021 | 76 | -38 | -26 | -13 | N/A |
| 12/31/2020 | 71 | -33 | -30 | -19 | N/A |
| 9/30/2020 | 71 | -23 | -34 | -25 | N/A |
| 6/30/2020 | 70 | -22 | -31 | -22 | N/A |
| 3/31/2020 | 74 | -15 | -32 | -21 | N/A |
| 12/31/2019 | 73 | -13 | -30 | -18 | N/A |
| 9/30/2019 | 68 | -11 | -24 | -14 | N/A |
| 6/30/2019 | 63 | -10 | -24 | -14 | N/A |
| 3/31/2019 | 60 | -10 | -22 | -14 | N/A |
| 12/31/2018 | 58 | -12 | -21 | -16 | N/A |
| 9/30/2018 | 55 | -25 | -23 | -16 | N/A |
| 6/30/2018 | 51 | -26 | N/A | -15 | N/A |
| 3/31/2018 | 48 | -26 | N/A | -12 | N/A |
| 12/31/2017 | 46 | -24 | N/A | -7 | N/A |
| 9/30/2017 | 43 | -14 | N/A | -3 | N/A |
| 6/30/2017 | 41 | -13 | N/A | -3 | N/A |
| 3/31/2017 | 39 | -12 | N/A | 1 | N/A |
| 12/31/2016 | 37 | -12 | N/A | -1 | N/A |
| 3/31/2016 | 33 | -12 | N/A | -2 | N/A |
| 12/31/2015 | 31 | -13 | N/A | -1 | N/A |
| 12/31/2014 | 24 | -13 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2X7 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2X7 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2X7 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2X7's revenue (16.8% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 2X7's revenue (16.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2X7's Return on Equity is forecast to be high in 3 years time